Fluorodeoxyglucose positron emission tomography (FDG-PET) effectively predicts lymph node status and prognosis in patients with esophageal squamous cell carcinoma (ESCC) undergoing esophagectomy after neoadjuvant chemotherapy (NCT). Researchers reviewed data from 124 ESCC patients and found that FDG-PET pre- and post-NCT correlated significantly with pathological lymph node metastasis, with post-NCT assessments serving as an independent predictor of both recurrence-free survival and overall survival. This indicates that FDG-PET can guide individualized treatment strategies in ESCC patients.
Journal Article by Ohsawa M, Hamai Y (…) Okada M et 6 al. in World J Surg
© 2024 International Society of Surgery/Société Internationale de Chirurgie (ISS/SIC).